Experienced in Palmoplantar Keratoderma

Vinod K. Sharma

NH58, Partapur Bypass Meerut-250103, 
Partapur, MH, IN 
Experienced in Palmoplantar Keratoderma
NH58, Partapur Bypass Meerut-250103, 
Partapur, MH, IN 
OverviewLocationsClinical Research

Overview

Vinod Sharma practices in Partapur, India. Mr. Sharma is rated as an Experienced expert by MediFind in the treatment of Palmoplantar Keratoderma. His top areas of expertise are Vitiligo, Hypomelanotic Disorder, Pemphigus Vulgaris, and Pemphigus.

His clinical research consists of co-authoring 144 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Palmoplantar Keratoderma.

Gender
Male

Locations

NH58, Partapur Bypass Meerut-250103, Partapur, MH 250103, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Outpatient Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Baricitinib in Pediatric Patients With Moderate to Severe Atopic Dermatitis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Outpatient Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Baricitinib in Pediatric Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, Topical Corticosteroid
Study Phase: Phase 3
A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: August 18, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

144 Total Publications

Psychological impacts of AI-induced job displacement among Indian IT professionals: a Delphi-validated thematic analysis.
Psychological impacts of AI-induced job displacement among Indian IT professionals: a Delphi-validated thematic analysis.
Journal: International journal of qualitative studies on health and well-being
Published: September 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sharma's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 57 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile